Back to News
Market Impact: 0.38
ADARx Pharmaceuticals raises $446.3 million in upsized US IPO
Source: reuters.com
IPOs & SPACsHealthcare & BiotechInvestor Sentiment & Positioning
ADARx Pharmaceuticals raised $446.3 million in an upsized U.S. IPO, signaling strong demand for the biotech issuer. The deal reflects growing investor appetite for biotechnology listings and is a constructive indicator for the sector's new-issuance market.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
strongly positive
Sentiment Score
0.55
More News
- Bond market alarms are ringing on Wall Street. Here's what's ahead
- Bonds Stabilize as Oil Retreats
- 10-year Treasury yield hit a 19-year high—and some investors see opportunity to buy bonds
- US, Iran Said to Be Exploring Phased Deal to Open Hormuz
- Wall Street Week | China’s Trade Reckoning, Syracuse’s Second Chance, Humanoids in Healthcare
- Microsoft gives Copilot a much-needed overhaul, and the stock deservedly soars